950160.KQ
Kolon TissueGene, Inc.
KOE · Healthcare · Biotechnology · US
KRW 16,910.00
−5.53%Leverage
- Debt / equity
- 0.31x
- Net debt / equity
- -0.02x
- Debt / assets
- 0.12x
- Debt / EBITDA
- -0.52x
- Net debt / EBITDA
- 0.04x
Liquidity & coverage
- Current ratio
- 0.33x
- Quick ratio
- 0.33x
- Cash ratio
- 0.31x
- Interest coverage
- -229.00x
- EBITDA / interest
- —
- Working capital
- -KRW 204.6B
Cash & dividend
- FCF / debt
- -0.98x
- Cash flow / debt
- -0.28x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026